Regulatory
Key facts
Mangoceuticals, Inc. announced it received an additional 180-calendar-day extension from Nasdaq
Key facts
The extension is to regain compliance with Nasdaq Listing Rule 5550(a)(2), the minimum bid price requirement
Key facts
Mangoceuticals has until February 1, 2027 to meet the minimum bid price requirement
Atlas Watchline
Mangoceuticals said Nasdaq gave it more time to meet the exchange’s minimum bid-price rule as it…